These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16299535)

  • 1. Modulation of cell function by small transmembrane proteins modeled on the bovine papillomavirus E5 protein.
    Freeman-Cook LL; Dimaio D
    Oncogene; 2005 Nov; 24(52):7756-62. PubMed ID: 16299535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of cell transformation by papillomavirus E5 proteins.
    DiMaio D; Mattoon D
    Oncogene; 2001 Nov; 20(54):7866-73. PubMed ID: 11753669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific locations of hydrophilic amino acids in constructed transmembrane ligands of the platelet-derived growth factor beta receptor.
    Freeman-Cook LL; Edwards AP; Dixon AM; Yates KE; Ely L; Engelman DM; Dimaio D
    J Mol Biol; 2005 Jan; 345(4):907-21. PubMed ID: 15588835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection and characterization of small random transmembrane proteins that bind and activate the platelet-derived growth factor beta receptor.
    Freeman-Cook LL; Dixon AM; Frank JB; Xia Y; Ely L; Gerstein M; Engelman DM; DiMaio D
    J Mol Biol; 2004 May; 338(5):907-20. PubMed ID: 15111056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface.
    Marchetti B; Ashrafi GH; Tsirimonaki E; O'Brien PM; Campo MS
    Oncogene; 2002 Nov; 21(51):7808-16. PubMed ID: 12420217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural models of the bovine papillomavirus E5 protein.
    Surti T; Klein O; Aschheim K; DiMaio D; Smith SO
    Proteins; 1998 Dec; 33(4):601-12. PubMed ID: 9849943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transactivation of the cyclin A promoter by bovine papillomavirus type 4 E5 protein.
    Grindlay GJ; Campo MS; O'Brien V
    Virus Res; 2005 Mar; 108(1-2):29-38. PubMed ID: 15681052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformation of mortal human fibroblasts and activation of a growth inhibitory pathway by the bovine papillomavirus E5 oncoprotein.
    Petti LM; Ray FA
    Cell Growth Differ; 2000 Jul; 11(7):395-408. PubMed ID: 10939593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the transmembrane dimer interface of the bovine papillomavirus E5 protein.
    Mattoon D; Gupta K; Doyon J; Loll PJ; DiMaio D
    Oncogene; 2001 Jun; 20(29):3824-34. PubMed ID: 11439346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple transmembrane amino acid requirements suggest a highly specific interaction between the bovine papillomavirus E5 oncoprotein and the platelet-derived growth factor beta receptor.
    Nappi VM; Petti LM
    J Virol; 2002 Aug; 76(16):7976-86. PubMed ID: 12134002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bovine papillomavirus E5 protein and the PDGF beta receptor: it takes two to tango.
    Talbert-Slagle K; DiMaio D
    Virology; 2009 Feb; 384(2):345-51. PubMed ID: 18990418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine papillomavirus E5 oncoprotein binds to the activated form of the platelet-derived growth factor beta receptor in naturally occurring bovine urinary bladder tumours.
    Borzacchiello G; Russo V; Gentile F; Roperto F; Venuti A; Nitsch L; Campo MS; Roperto S
    Oncogene; 2006 Feb; 25(8):1251-60. PubMed ID: 16205631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The E5 oncoprotein of BPV-4 does not interfere with the biosynthetic pathway of non-classical MHC class I.
    Araibi EH; Marchetti B; Dornan ES; Ashrafi GH; Dobromylskyj M; Ellis SA; Campo MS
    Virology; 2006 Sep; 353(1):174-83. PubMed ID: 16806386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable association between the bovine papillomavirus E5 transforming protein and activated platelet-derived growth factor receptor in transformed mouse cells.
    Petti L; DiMaio D
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6736-40. PubMed ID: 1323117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptors.
    Martin P; Vass WC; Schiller JT; Lowy DR; Velu TJ
    Cell; 1989 Oct; 59(1):21-32. PubMed ID: 2551505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The platelet-derived growth factor beta receptor as a target of the bovine papillomavirus E5 protein.
    DiMaio D; Lai CC; Mattoon D
    Cytokine Growth Factor Rev; 2000 Dec; 11(4):283-93. PubMed ID: 10959076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine papillomavirus type 1 oncoprotein E5 stimulates the utilization of superoxide radicals in the mouse fibroblast cell line C127.
    Kilk A; Rausalu K; Ustav M
    Chem Biol Interact; 2006 Feb; 159(3):205-12. PubMed ID: 16413007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine papillomavirus E5 protein induces the formation of signal transduction complexes containing dimeric activated platelet-derived growth factor beta receptor and associated signaling proteins.
    Lai CC; Henningson C; DiMaio D
    J Biol Chem; 2000 Mar; 275(13):9832-40. PubMed ID: 10734138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological properties of the deer papillomavirus E5 gene in mouse C127 cells: growth transformation, induction of DNA synthesis, and activation of the platelet-derived growth factor receptor.
    Kulke R; DiMaio D
    J Virol; 1991 Sep; 65(9):4943-9. PubMed ID: 1651413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Productive interaction between transmembrane mutants of the bovine papillomavirus E5 protein and the platelet-derived growth factor beta receptor.
    Lai CC; Edwards AP; DiMaio D
    J Virol; 2005 Feb; 79(3):1924-9. PubMed ID: 15650217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.